PL3544615T3 - Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego - Google Patents

Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego

Info

Publication number
PL3544615T3
PL3544615T3 PL17812273.5T PL17812273T PL3544615T3 PL 3544615 T3 PL3544615 T3 PL 3544615T3 PL 17812273 T PL17812273 T PL 17812273T PL 3544615 T3 PL3544615 T3 PL 3544615T3
Authority
PL
Poland
Prior art keywords
escin
beta
oral compositions
reducing acetaldehyde
chokeberry juice
Prior art date
Application number
PL17812273.5T
Other languages
English (en)
Inventor
Katarzyna KOZIAK
Original Assignee
Escilab Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Escilab Spółka Z Ograniczoną Odpowiedzialnością filed Critical Escilab Spółka Z Ograniczoną Odpowiedzialnością
Publication of PL3544615T3 publication Critical patent/PL3544615T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Addiction (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
PL17812273.5T 2016-11-24 2017-11-24 Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego PL3544615T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1619846.7A GB201619846D0 (en) 2016-11-24 2016-11-24 Saponin composition
PCT/IB2017/057395 WO2018096502A1 (en) 2016-11-24 2017-11-24 Oral compositions comprising beta-escin for reducing acetaldehyde toxicity

Publications (1)

Publication Number Publication Date
PL3544615T3 true PL3544615T3 (pl) 2022-09-19

Family

ID=58073282

Family Applications (2)

Application Number Title Priority Date Filing Date
PL430029A PL430029A1 (pl) 2016-11-24 2017-11-24 Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu
PL17812273.5T PL3544615T3 (pl) 2016-11-24 2017-11-24 Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL430029A PL430029A1 (pl) 2016-11-24 2017-11-24 Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu

Country Status (9)

Country Link
US (1) US10799550B2 (pl)
EP (1) EP3544615B1 (pl)
JP (1) JP7070933B2 (pl)
KR (1) KR102569055B1 (pl)
AU (1) AU2017365116B2 (pl)
CA (1) CA3044504A1 (pl)
GB (1) GB201619846D0 (pl)
PL (2) PL430029A1 (pl)
WO (1) WO2018096502A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020070732A1 (en) * 2018-10-05 2020-04-09 Escilab Sp Z O. O. Oral composition comprising β-escin and the use thereof
CN116159145B (zh) * 2023-01-31 2025-04-22 四川大学 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3533231B2 (ja) * 1993-08-20 2004-05-31 森下仁丹株式会社 アルコール吸収抑制剤
JP4777495B2 (ja) * 1999-04-01 2011-09-21 森下仁丹株式会社 アルコール障害予防剤およびそれを含有する食品
US20080299250A1 (en) * 2005-12-30 2008-12-04 Cadbury Holdings Limited Chewing Gum Composition Containing Chokeberry
KR101383276B1 (ko) * 2012-03-05 2014-04-08 염장열 아로니아 음료 농축액 및 그 제조방법
KR20140090453A (ko) * 2013-01-09 2014-07-17 (주) 제이비케이자연의학연구소 아로니아 추출물을 함유하는 숙취예방, 숙취해소 또는 간 보호용 조성물
PL405318A1 (pl) * 2013-09-11 2015-03-16 Cezary Bilski Preparat złożony wspomagający odchudzanie na bazie wyciągów roślinnych
KR20160100572A (ko) * 2015-02-16 2016-08-24 학교법인연세대학교 고미가 제거된 남가새 음료 및 이의 제조방법
EP3078381A1 (en) * 2015-04-10 2016-10-12 Warszawski Uniwersytet Medyczny Horse chestnut extract or escins for the treatment of alzheimer's disease

Also Published As

Publication number Publication date
CA3044504A1 (en) 2018-05-31
JP2019535779A (ja) 2019-12-12
US20190321432A1 (en) 2019-10-24
EP3544615B1 (en) 2022-05-18
US10799550B2 (en) 2020-10-13
WO2018096502A1 (en) 2018-05-31
AU2017365116A1 (en) 2019-05-23
GB201619846D0 (en) 2017-01-11
EP3544615A1 (en) 2019-10-02
AU2017365116B2 (en) 2023-06-22
KR20190087437A (ko) 2019-07-24
JP7070933B2 (ja) 2022-05-18
KR102569055B1 (ko) 2023-08-21
PL430029A1 (pl) 2021-03-08

Similar Documents

Publication Publication Date Title
IL278891A (en) Anti-HER2 drug-antibody conjugates, preparations containing them and their uses
IL258082B (en) History of benzaimidazole and pharmaceutical preparations containing them
ZA201801511B (en) Flavonoid compositions and methods of use
PL3628691T3 (pl) Amfifilowe pochodne polisacharydów i zawierające je kompozycje
SI3426348T1 (sl) Derivat 3-dezoksi in njegovi farmacevtski sestavki
IL247836A0 (en) 1, 3-benzodioxole derivatives, preparations containing them and their uses
IL271275B1 (en) Preparations containing croons and their uses
ZA201801692B (en) 17-hydroxyprogesterone ester-containing oral compositions and related methods
EP3223609A4 (en) Novel diterpene glycosides, compositions and purification methods
IL271759A (en) Pharmaceutical preparations that include anthraxtinib
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
PL3253231T3 (pl) Kompozycje przeciwdrobnoustrojowe zawierające ekstrakty z Punica i Lamiaceae
CA3297520A1 (en) Synergistic glycocalyx treatment compositions and methods
PL3258948T3 (pl) Kompozycje przeciwzapalne i immunomodulujące zawierające klebsormidium i ich zastosowania
IL248773B (en) History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them
GB201502002D0 (en) Uses and compositions
IL266840A (en) History of tyrosine and preparations containing them
EP3223632A4 (en) Novel diterpene glycosides, compositions and purification methods
SG10202106375UA (en) Pharmaceutical compositions and use thereof
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
IL254711B (en) History of diazepine-indole and medicinal preparations containing them
PL3544615T3 (pl) Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego
PL3568203T3 (pl) Związki i kompozycje
EP3223608A4 (en) Novel diterpene glycosides, compositions and purification methods